Home › Companies › ELANCO ANIMAL HEALTH INC. › 2024-2025

ELANCO ANIMAL HEALTH INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and ELANCO ANIMAL HEALTH INC.’s Form 8-K, filed May 21, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.

5Reported items
381Asset managers
2,740Fund votes
May 16, 2025Meeting date

Results at a glance

Meeting of May 16, 2025: 4 items on ELANCO ANIMAL HEALTH INC.’s Form 8-K, filed May 21, 2025: 2 elected · 2 approved.

Material dissent

Elect Director: Kapila K. Anand 66% of votes cast Elected Director under 80%
3. By non-binding vote, the compensation of Elanco's named executive officers 53.5% of votes cast Approved Say-on-pay under 70%

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore ELANCO ANIMAL HEALTH INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by ELANCO ANIMAL HEALTH INC.

These tallies are ELANCO ANIMAL HEALTH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 21, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ELANCO ANIMAL HEALTH INC. — official shareholder meeting results, meeting held May 16, 2025
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Kapila K. Anand	300,900,004	156,032,826	208,081	--	16,176,812	66%	Elected	—
Elect Director: Paul Herendeen	432,060,248	24,992,504	88,159	--	16,176,812	95%	Elected	—
2. The appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2025	470,067,158	3,077,086	173,479	--	--	99.3%	Approved	—
3. By non-binding vote, the compensation of Elanco's named executive officers	244,532,049	212,491,837	117,025	--	16,176,812	53.5%	Approved	—

Source: ELANCO ANIMAL HEALTH INC., Form 8-K, filed with the SEC on May 21, 2025 — read the filing on EDGAR.

How asset managers voted at the ELANCO ANIMAL HEALTH INC. 2024-2025 meeting

Each item below shows how the 381 asset managers that disclosed a ELANCO ANIMAL HEALTH INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ELANCO ANIMAL HEALTH INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Kapila K. Anand

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

66% Majority: yes · of votes cast

FOR 66%AGAINST

FOR: 300,900,004AGAINST: 156,032,826

Details: description as filed, official tally, votes by 81 asset managers

Description as filed by funds: ELECTION OF DIRECTOR: KAPILA ANAND

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“Elect Director: Kapila K. Anand”): 300,900,004 for, 156,032,826 against, per its Form 8-K filed May 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2026 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 66% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 81 asset managers below reported 143,149,359 for, 127,850,867 against, 19,745 abstained.

FORAGAINST

FOR: 143,149,359AGAINST: 127,850,867ABSTAIN: 19,745

Largest asset managers voting on “ELECTION OF DIRECTOR: KAPILA ANAND” at ELANCO ANIMAL HEALTH INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	48,286,384	37,173,746	Mixed
Dodge & Cox	0	64,825,000	Against
Fidelity	41,372,512	0	For
Dimensional	0	17,338,299	Against
PRIMECAP Odyssey Funds	0	7,322,594	Against
TIAA	7,193,043	0	For
Bridge Builder Trust	6,598,158	0	For
BlackRock	6,039,222	0	For
T. Rowe Price	5,835,103	0	For
Charles Schwab	4,681,506	0	For
Prudential/PGIM	4,257,295	62,299	For
Nuveen	3,427,618	0	For
John Hancock	2,765,273	452,355	Mixed
First Trust	1,808,904	0	For
Federated Hermes	1,448,451	0	For
Harbor Funds II	1,084,629	0	For
VanEck ETF Trust	784,046	0	For
AMERICAN BEACON FUNDS	639,082	0	For
Empower	583,223	0	For
Goldman Sachs	480,342	0	For
Hartford	443,456	0	For
Jackson National	349,932	93,073	Mixed
Datum One Series Trust	0	411,029	Against
Virtus	358,695	0	For
MASTER INVESTMENT PORTFOLIO	340,844	0	For

Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.

2. Elect Director: Paul Herendeen

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 432,060,248AGAINST: 24,992,504

Details: description as filed, official tally, votes by 81 asset managers

Description as filed by funds: ELECTION OF DIRECTOR: PAUL HERENDEEN

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“Elect Director: Paul Herendeen”): 432,060,248 for, 24,992,504 against, per its Form 8-K filed May 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2026 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 81 asset managers below reported 252,491,079 for, 18,525,072 against, 3,820 abstained.

FOR

FOR: 252,491,079AGAINST: 18,525,072ABSTAIN: 3,820

Largest asset managers voting on “ELECTION OF DIRECTOR: PAUL HERENDEEN” at ELANCO ANIMAL HEALTH INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	85,460,127	3	For
Dodge & Cox	64,825,000	0	For
Fidelity	41,372,512	0	For
Dimensional	0	17,338,299	Against
PRIMECAP Odyssey Funds	7,322,594	0	For
TIAA	7,193,043	0	For
Bridge Builder Trust	6,598,158	0	For
BlackRock	6,039,222	0	For
T. Rowe Price	5,835,103	0	For
Charles Schwab	4,681,506	0	For
Prudential/PGIM	4,257,295	62,299	For
Nuveen	3,427,618	0	For
John Hancock	2,765,273	452,355	Mixed
First Trust	1,808,904	0	For
Federated Hermes	1,448,451	0	For
Harbor Funds II	1,084,629	0	For
VanEck ETF Trust	784,046	0	For
AMERICAN BEACON FUNDS	639,082	0	For
Empower	583,223	0	For
Goldman Sachs	480,342	0	For
Hartford	443,456	0	For
Jackson National	349,932	93,073	Mixed
Datum One Series Trust	0	411,029	Against
Virtus	358,695	0	For
MASTER INVESTMENT PORTFOLIO	340,844	0	For

Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.

3. 3. By non-binding vote, the compensation of Elanco's named executive officers

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 10 wordings of this item as funds reported it.

53.5% Approved · of votes cast

FOR 53.5%AGAINST

FOR: 244,532,049AGAINST: 212,491,837

Details: description as filed, official tally, votes by 378 asset managers

Description as filed by funds: Advisory vote on the compensation of the company's named executive officers.

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“3. By non-binding vote, the compensation of Elanco's named executive officers”): 244,532,049 for, 212,491,837 against — passed, per its Form 8-K filed May 21, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved, by non-binding vote, the compensation of Elanco's named executive officers, by the votes set forth in the table below.”
Support: 53.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports: 82 asset managers voting on “Advisory vote on the compensation of the company's named executive officers.” at ELANCO ANIMAL HEALTH INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	47,879,095	37,581,035	Mixed
Dodge & Cox	0	64,825,000	Against
Fidelity	41,372,512	0	For
Dimensional	0	17,338,299	Against
PRIMECAP Odyssey Funds	0	7,322,594	Against
TIAA	0	7,193,043	Against
Bridge Builder Trust	1,486,403	5,111,755	Mixed
BlackRock	6,039,222	0	For
T. Rowe Price	5,835,103	0	For
Charles Schwab	4,681,506	0	For
Prudential/PGIM	0	4,319,594	Against
Nuveen	0	3,427,618	Against
John Hancock	2,765,273	452,355	Mixed
First Trust	1,808,904	0	For
Federated Hermes	0	1,448,451	Against
Harbor Funds II	1,084,629	0	For
VanEck ETF Trust	0	784,046	Against
AMERICAN BEACON FUNDS	639,082	0	For
Empower	583,223	0	For
Goldman Sachs	480,342	0	For
Hartford	0	443,456	Against
Jackson National	349,932	93,073	Mixed
Datum One Series Trust	0	411,029	Against
Virtus	0	358,695	Against
MASTER INVESTMENT PORTFOLIO	340,844	0	For

Fund voting reports, all 82 managers: 118,305,105 for, 152,711,239 against, 3,820 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 320 asset managers voting on “Advisory vote on the compensation of the company's named executive officers.” at ELANCO ANIMAL HEALTH INC., 2024-2025
Asset manager	For	Against	Vote
Dodge & Cox	0	78,698,810	Against
PRIMECAP MANAGEMENT CO/CA/	0	47,191,081	Against
Fidelity	42,627,981	0	For
Black Creek Investment Management Inc.	21,512,121	0	For
T. Rowe Price	16,386,521	0	For
BlackRock	12,319,490	200,034	For
Nuveen	26,175	10,832,543	Against
SHAPIRO CAPITAL MANAGEMENT LLC	10,759,222	0	For
GEODE CAPITAL MANAGEMENT, LLC	8,218,422	0	For
State Street	7,156,862	2,002	For
BARROW HANLEY MEWHINNEY & STRAUSS LLC	0	6,644,355	Against
John Hancock	6,608,376	0	For
Charles Schwab	5,265,798	0	For
Prudential/PGIM	0	4,519,151	Against
BRANDES INVESTMENT PARTNERS, LP	0	3,593,847	Against
Utah Retirement Systems	3,219,892	0	For
Wellington	0	3,096,068	Against
Goldman Sachs	2,724,360	0	For
PRIVATE MANAGEMENT GROUP INC	2,534,732	0	For
PARAMETRIC PORTFOLIO ASSOCIATES LLC	2,486,538	0	For
Northern Trust	2,421,549	1,257	For
Dimensional	0	2,265,709	Against
Federated Hermes	0	2,157,624	Against
ASR Vermogensbeheer N.V.	0	2,151,935	Against
JUPITER ASSET MANAGEMENT LTD	1,748,320	0	For

Institutional-manager reports, all 320 managers: 160,481,361 for, 175,616,748 against, 40,326 not voted, 159,476 1 year. Showing the 25 largest; see all in the interactive database.

4. Advisory vote on the frequency with which shareholders vote on the compensation of the company's named executive…

No official match Fund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

97% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR

Details: description as filed, votes by 363 asset managers

Description as filed by funds: Advisory vote on the frequency with which shareholders vote on the compensation of the company's named executive officers.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 78 asset managers voting on “Advisory vote on the frequency with which shareholders vote on the compensation of the company's named executi” at ELANCO ANIMAL HEALTH INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Vanguard	0	0	0	0	--
Dodge & Cox	0	0	0	0	--
Fidelity	0	0	0	0	--
Dimensional	0	0	0	0	--
PRIMECAP Odyssey Funds	0	0	0	0	--
TIAA	0	0	0	0	--
Bridge Builder Trust	0	0	0	0	--
BlackRock	0	0	0	0	--
T. Rowe Price	0	0	0	0	--
Charles Schwab	0	0	0	0	--
Prudential/PGIM	0	0	0	0	--
Nuveen	0	0	0	0	--
John Hancock	0	0	0	0	--
First Trust	0	0	0	0	--
Federated Hermes	0	0	0	0	--
Harbor Funds II	0	0	0	0	--
VanEck ETF Trust	0	0	0	0	--
AMERICAN BEACON FUNDS	0	0	0	0	--
Goldman Sachs	0	0	0	0	--
Hartford	0	0	0	0	--
Jackson National	0	0	0	0	--
Datum One Series Trust	0	0	0	0	--
Virtus	0	0	0	0	--
MASTER INVESTMENT PORTFOLIO	0	0	0	0	--
PIMCO	0	0	0	0	--

Fund voting reports, all 78 managers: 107,798 for, 3,820 abstained, 252,121,226 1 year, 18,041,211 3 year, 1 unknown, 0 2 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 309 asset managers voting on “Advisory vote on the frequency with which shareholders vote on the compensation of the company's named executi” at ELANCO ANIMAL HEALTH INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Dodge & Cox	0	0	0	0	--
PRIMECAP MANAGEMENT CO/CA/	0	0	0	0	--
Fidelity	0	0	0	0	--
Black Creek Investment Management Inc.	0	0	0	0	--
T. Rowe Price	0	0	0	0	--
BlackRock	0	0	0	0	--
Nuveen	0	0	0	0	--
SHAPIRO CAPITAL MANAGEMENT LLC	0	0	0	0	--
GEODE CAPITAL MANAGEMENT, LLC	0	0	0	0	--
State Street	0	0	0	0	--
BARROW HANLEY MEWHINNEY & STRAUSS LLC	0	0	0	0	--
John Hancock	0	0	0	0	--
Charles Schwab	0	0	0	0	Not Voted
Prudential/PGIM	0	0	0	0	--
BRANDES INVESTMENT PARTNERS, LP	0	0	0	0	--
Utah Retirement Systems	0	0	0	0	--
Wellington	0	0	0	0	--
Goldman Sachs	0	0	0	0	--
PRIVATE MANAGEMENT GROUP INC	0	0	0	0	--
PARAMETRIC PORTFOLIO ASSOCIATES LLC	0	0	0	0	--
Northern Trust	0	0	0	0	--
Dimensional	0	0	0	0	--
Federated Hermes	0	0	0	0	--
ASR Vermogensbeheer N.V.	0	0	0	0	--
JUPITER ASSET MANAGEMENT LTD	0	0	0	0	--

Institutional-manager reports, all 309 managers: 190,783 for, 9,599 against, 40,221 not voted, 331,741,048 1 year, 2,800,394 3 year, 117 2 year. Showing the 25 largest; see all in the interactive database.

5. 2. The appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2025

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

99.3% Approved · of votes cast

FOR 99.3%

FOR: 470,067,158AGAINST: 3,077,086

Details: description as filed, official tally, votes by 82 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2025.

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“2. The appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2025”): 470,067,158 for, 3,077,086 against — passed, per its Form 8-K filed May 21, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders ratified the appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2025, by the votes set forth in the table below.”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 82 asset managers below reported 270,974,652 for, 41,692 against, 3,820 abstained.

FOR

FOR: 270,974,652AGAINST: 41,692ABSTAIN: 3,820

Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING” at ELANCO ANIMAL HEALTH INC., 2024-2025
Asset manager	For	Vote
Vanguard	85,460,130	For
Dodge & Cox	64,825,000	For
Fidelity	41,372,512	For
Dimensional	17,338,299	For
PRIMECAP Odyssey Funds	7,322,594	For
TIAA	7,193,043	For
Bridge Builder Trust	6,598,158	For
BlackRock	6,039,222	For
T. Rowe Price	5,835,103	For
Charles Schwab	4,681,506	For
Prudential/PGIM	4,319,594	For
Nuveen	3,427,618	For
John Hancock	3,217,628	For
First Trust	1,808,904	For
Federated Hermes	1,448,451	For
Harbor Funds II	1,084,629	For
VanEck ETF Trust	784,046	For
AMERICAN BEACON FUNDS	639,082	For
Empower	583,223	For
Goldman Sachs	480,342	For
Hartford	443,456	For
Jackson National	443,005	For
Datum One Series Trust	411,029	For
Virtus	358,695	For
MASTER INVESTMENT PORTFOLIO	340,844	For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

Largest ELANCO ANIMAL HEALTH INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 496,458,420 shares outstanding at the time of that meeting.

Fund voting reports: top ELANCO ANIMAL HEALTH INC. shareholders by shares voted on “Advisory vote on the compensation of the company's named executive officers.”, 2024-2025
#	Asset manager	% of shares outstanding
1	Vanguard	17.21%
2	Dodge & Cox	13.06%
3	Fidelity	8.33%
4	Dimensional	3.49%
5	PRIMECAP Odyssey Funds	1.47%
6	TIAA	1.45%
7	Bridge Builder Trust	1.33%
8	BlackRock	1.22%
9	T. Rowe Price	1.18%
10	Charles Schwab	0.94%

Institutional-manager reports: top ELANCO ANIMAL HEALTH INC. shareholders by shares voted on “Advisory vote on the compensation of the company's named executive officers.”, 2024-2025
#	Asset manager	% of shares outstanding
1	Dodge & Cox	15.85%
2	PRIMECAP MANAGEMENT CO/CA/	9.51%
3	Fidelity	8.59%
4	Black Creek Investment Management Inc.	4.33%
5	T. Rowe Price	3.30%
6	BlackRock	2.52%
7	Nuveen	2.19%
8	SHAPIRO CAPITAL MANAGEMENT LLC	2.17%
9	GEODE CAPITAL MANAGEMENT, LLC	1.66%
10	State Street	1.44%

Reported ELANCO ANIMAL HEALTH INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

ELANCO ANIMAL HEALTH INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
Dodge & Cox	13.89%	13G
FMR (Fidelity)	10.85%	13F
Vanguard Group	9.73%	13F
PRIMECAP MANAGEMENT CO/CA/	9.23%	13G
T. Rowe Price Investment Management, Inc.	6.35%	13G
BlackRock	4.78%	13F
Dimensional Fund Advisors	4.12%	13F
Nuveen	2.37%	13F
State Street	1.86%	13F
Goldman Sachs	0.96%	13F

Percentages above are of 496,458,420 shares outstanding, as reported by ELANCO ANIMAL HEALTH INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ELANCO ANIMAL HEALTH INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At ELANCO ANIMAL HEALTH INC.'s shareholder meeting held May 16, 2025, in the 2024-2025 proxy season, 381 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,740 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory vote on the compensation of the company's named executive officers. — ELANCO ANIMAL HEALTH INC.'s filing reports the proposal as approved, with 53.5% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ELANCO ANIMAL HEALTH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 21, 2025.

ELANCO ANIMAL HEALTH INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.